A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Medtronic’s Q3 AIMD Earnings: CRM 3% Down, Neuromodulation 4% Up

Today Medtronic announced financial results for its third quarter of fiscal year 2012, which ended January 27, 2012. According to the report: “CRDM third quarter revenue of $1.192 billion decreased 2 percent as reported or 3% on a constant currency basis. Third quarter revenue from ICDs was $674 million,  down 9 percent on a constant

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic’s Q3 AIMD Earnings: CRM 3% Down, Neuromodulation 4% Up  comments